Hepatitis C virus subverts liver-specific miR-122 to protect the viral genome from exoribonuclease Xrn2

Cell Host and Microbe

Volumn 16, Issue 2, 2014, Pages 257-264

  Sedano, Cecilia D ^a   Sarnow, Peter ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXORIBONUCLEASE; EXORIBONUCLEASE XRN2; MICRORNA 122; MICRORNA 124; UNCLASSIFIED DRUG; VIRUS RNA; MICRORNA; MIRN122 MICRORNA, HUMAN; XRN2 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; GENE SILENCING; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; RNA DEGRADATION; RNA METABOLISM; RNA REPLICATION; RNA STABILITY; VIRUS GENOME; GENETICS; HEPACIVIRUS; HOST PATHOGEN INTERACTION; METABOLISM; PROTEIN TRANSPORT; RNA CLEAVAGE; TUMOR CELL LINE; VIRUS REPLICATION;

CELL LINE, TUMOR; EXORIBONUCLEASES; GENOME, VIRAL; HEPACIVIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; MICRORNAS; PROTEIN TRANSPORT; RNA CLEAVAGE; RNA STABILITY; RNA, VIRAL; VIRUS REPLICATION;

EID: 84920123049     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2014.07.006     Document Type: Article

References (32)

1. R. Bartenschlager, F. Penin, V. Lohmann, and P. André Assembly of infectious hepatitis C virus particles Trends Microbiol. 19 2011 95 103
2. B. Benoit, G. Mitou, A. Chartier, C. Temme, S. Zaessinger, E. Wahle, I. Busseau, and M. Simonelig An essential cytoplasmic function for the nuclear poly(A) binding protein, PABP2, in poly(A) tail length control and early development in Drosophila Dev. Cell 9 2005 511 522
3. S. Chatterjee, and H. Grosshans Active turnover modulates mature microRNA activity in Caenorhabditis elegans Nature 461 2009 546 549
4. M.D. Cleary, C.D. Meiering, E. Jan, R. Guymon, and J.C. Boothroyd Biosynthetic labeling of RNA with uracil phosphoribosyltransferase allows cell-specific microarray analysis of mRNA synthesis and decay Nat. Biotechnol. 23 2005 232 237
5. A. El Hage, M. Koper, J. Kufel, and D. Tollervey Efficient termination of transcription by RNA polymerase I requires the 5′ exonuclease Rat1 in yeast Genes Dev. 22 2008 1069 1081
6. J. Elmén, M. Lindow, S. Schütz, M. Lawrence, A. Petri, S. Obad, M. Lindholm, M. Hedtjärn, H.F. Hansen, and U. Berger et al. LNA-mediated microRNA silencing in non-human primates Nature 452 2008 896 899
7. Y. Henry, H. Wood, J.P. Morrissey, E. Petfalski, S. Kearsey, and D. Tollervey The 5′ end of yeast 5.8S rRNA is generated by exonucleases from an upstream cleavage site EMBO J. 13 1994 2452 2463
8. J.H. Hoofnagle Course and outcome of hepatitis C Hepatology 36 Suppl 1 2002 S21 S29
9. H.L. Janssen, H.W. Reesink, E.J. Lawitz, S. Zeuzem, M. Rodriguez-Torres, K. Patel, A.J. van der Meer, A.K. Patick, A. Chen, and Y. Zhou et al. Treatment of HCV infection by targeting microRNA N. Engl. J. Med. 368 2013 1685 1694
10. C.L. Jopling, M. Yi, A.M. Lancaster, S.M. Lemon, and P. Sarnow Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA Science 309 2005 1577 1581
11. C.L. Jopling, S. Schütz, and P. Sarnow Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome Cell Host Microbe 4 2008 77 85
12. M. Kim, N.J. Krogan, L. Vasiljeva, O.J. Rando, E. Nedea, J.F. Greenblatt, and S. Buratowski The yeast Rat1 exonuclease promotes transcription termination by RNA polymerase II Nature 432 2004 517 522
13. D. Lavanchy Evolving epidemiology of hepatitis C virus Clin. Microbiol. Infect. 17 2011 107 115
14. S. Li, L. Wang, M. Berman, Y.Y. Kong, and M.E. Dorf Mapping a dynamic innate immunity protein interaction network regulating type I interferon production Immunity 35 2011 426 440
15. Y. Li, T. Masaki, D. Yamane, D.R. McGivern, and S.M. Lemon Competing and noncompeting activities of miR-122 and the 5′ exonuclease Xrn1 in regulation of hepatitis C virus replication Proc. Natl. Acad. Sci. USA 110 2013 1881 1886
16. E.S. Machlin, P. Sarnow, and S.M. Sagan Masking the 5′ terminal nucleotides of the hepatitis C virus genome by an unconventional microRNA-target RNA complex Proc. Natl. Acad. Sci. USA 108 2011 3193 3198
17. E.S. Machlin, P. Sarnow, and S.M. Sagan Combating hepatitis C virus by targeting microRNA-122 using locked nucleic acids Curr. Gene Ther. 12 2012 301 306
18. G. Migliaccio, J.E. Tomassini, S.S. Carroll, L. Tomei, S. Altamura, B. Bhat, L. Bartholomew, M.R. Bosserman, A. Ceccacci, and L.F. Colwell et al. Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro J. Biol. Chem. 278 2003 49164 49170
19. T.S. Miki, H. Richter, S. Rüegger, and H. Großhans PAXT-1 promotes XRN2 activity by stabilizing it through a conserved domain Mol. Cell 53 2014 351 360
20. M. Morlando, M. Ballarino, P. Greco, E. Caffarelli, B. Dichtl, and I. Bozzoni Coupling between snoRNP assembly and 3′ processing controls box C/D snoRNA biosynthesis in yeast EMBO J. 23 2004 2392 2401
21. K.L. Norman, and P. Sarnow Modulation of hepatitis C virus RNA abundance and the isoprenoid biosynthesis pathway by microRNA miR-122 involves distinct mechanisms J. Virol. 84 2010 666-6670
22. C.T. Pager, S. Schütz, T.M. Abraham, G. Luo, and P. Sarnow Modulation of hepatitis C virus RNA abundance and virus release by dispersion of processing bodies and enrichment of stress granules Virology 435 2013 472 484
23. L.H. Qu, A. Henras, Y.J. Lu, H. Zhou, W.X. Zhou, Y.Q. Zhu, J. Zhao, Y. Henry, M. Caizergues-Ferrer, and J.P. Bachellerie Seven novel methylation guide small nucleolar RNAs are processed from a common polycistronic transcript by Rat1p and RNase III in yeast Mol. Cell. Biol. 19 1999 1144 1158
24. N. Scheller, L.B. Mina, R.P. Galão, A. Chari, M. Giménez-Barcons, A. Noueiry, U. Fischer, A. Meyerhans, and J. Díez Translation and replication of hepatitis C virus genomic RNA depends on ancient cellular proteins that control mRNA fates Proc. Natl. Acad. Sci. USA 106 2009 13517 13522
25. T. Shimakami, D. Yamane, R.K. Jangra, B.J. Kempf, C. Spaniel, D.J. Barton, and S.M. Lemon Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex Proc. Natl. Acad. Sci. USA 109 2012 941 946
26. A. Stevens, and M.K. Maupin A 5′ - - 3′ exoribonuclease of human placental nuclei: purification and substrate specificity Nucleic Acids Res. 15 1987 695 708
27. A. Stevens, and T.L. Poole 5′-exonuclease-2 of Saccharomyces cerevisiae. Purification and features of ribonuclease activity with comparison to 5′-exonuclease-1 J. Biol. Chem. 270 1995 16063 16069
28. N. Ternette, C. Wright, H.B. Kramer, M. Altun, and B.M. Kessler Label-free quantitative proteomics reveals regulation of interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) and 5′-3′- exoribonuclease 2 (XRN2) during respiratory syncytial virus infection Virol. J. 8 2011 442
29. T. Wakita, T. Pietschmann, T. Kato, T. Date, M. Miyamoto, Z. Zhao, K. Murthy, A. Habermann, H.G. Kräusslich, and M. Mizokami et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome Nat. Med. 11 2005 791 796
30. K.A. Wehner, S. Schütz, and P. Sarnow OGFOD1, a novel modulator of eukaryotic translation initiation factor 2alpha phosphorylation and the cellular response to stress Mol. Cell. Biol. 30 2010 2006 2016
31. S. West, N. Gromak, and N.J. Proudfoot Human 5′ - > 3′ exonuclease Xrn2 promotes transcription termination at co-transcriptional cleavage sites Nature 432 2004 522 525
32. S. Xiang, A. Cooper-Morgan, X. Jiao, M. Kiledjian, J.L. Manley, and L. Tong Structure and function of the 5′→3′ exoribonuclease Rat1 and its activating partner Rai1 Nature 458 2009 784 788